Nutrition study for babies with biliary atresia
Part of Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is under 3 months old.
- Your baby has been diagnosed with biliary atresia and needs Kasai surgery.
- You are willing to sign a consent form and follow the study plan.
- Your baby was not born with low or very low birth weight.
- Your baby does not have other serious health problems that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
This trial tests whether an oral medicine called N-acetylcysteine (NAC) is safe and well-tolerated in infants with biliary atresia. It looks for participants who are 4–9 months old, can eat and take medicines by mouth, and will stay in the hospital for at least 4 days.
This trial tests if giving umbilical cord stem cells along with a standard surgery (Kasai procedure) helps infants with biliary atresia. It aims to see if this combination can improve outcomes for babies diagnosed early.
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
This study enrolls children and young adults with biliary atresia (a condition where bile can’t flow properly from the liver) to learn from their care and outcomes over scheduled visits. It may help researchers understand the disease better and improve future treatment.
This study is testing whether stem cells can help infants with liver cirrhosis from biliary atresia (a blocked bile duct condition) who have already had Kasai surgery. It aims to see if stem cell therapy can improve liver function and reduce complications.
Hear when a new Nutrition Disorder, Infant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.